Curtius, K., Wright, N. A. & Graham, T. A. An evolutionary perspective on field cancerization. Nat. Rev. Cancer 18, 19–32 (2018).
Article CAS PubMed Google Scholar
Dotto, G. P. Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J. Clin. Invest. 124, 1446–1453 (2014).
Article CAS PubMed PubMed Central Google Scholar
Taniguchi, S. et al. Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression. Science 369, eaay1813 (2020).
Article CAS PubMed PubMed Central Google Scholar
Yuan, S. et al. Ras drives malignancy through stem cell crosstalk with the microenvironment. Nature 612, 555–563 (2022).
Article CAS PubMed PubMed Central Google Scholar
Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734–4752.e20 (2021).
Article CAS PubMed PubMed Central Google Scholar
Chen, J. H. et al. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat. Immunol. 25, 644–658 (2024).
Article CAS PubMed PubMed Central Google Scholar
Dong, L.-Q. et al. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma. J. Hepatol. 72, 896–908 (2020).
Article CAS PubMed Google Scholar
Zucman-Rossi, J., Villanueva, A., Nault, J.-C. & Llovet, J. M. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology 149, 1226–1239.e4 (2015).
Article CAS PubMed Google Scholar
Mu, X. et al. Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J. Clin. Invest. 125, 3891–3903 (2015).
Article PubMed PubMed Central Google Scholar
Libbrecht, L., Desmet, V. & Roskams, T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int. 25, 16–27 (2005).
Article CAS PubMed Google Scholar
Lefere, S., Degroote, H., Van Vlierberghe, H. & Devisscher, L. Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers. J. Hepatol. 71, 631–633 (2019).
Deng, Z. et al. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature 626, 864–873 (2024).
Article CAS PubMed PubMed Central Google Scholar
Yuan, D. et al. Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS. Cancer Cell 31, 771–789.e6 (2017).
Article CAS PubMed PubMed Central Google Scholar
Wu, J. et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res. 72, 3977–3986 (2012).
Article CAS PubMed PubMed Central Google Scholar
Blériot, C. et al. A subset of Kupffer cells regulates metabolism through the expression of CD36. Immunity 54, 2101–2116.e6 (2021).
De Simone, G. et al. Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming. Immunity 54, 2089–2100.e8 (2021).
Article PubMed PubMed Central Google Scholar
Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512–518 (2019).
Article CAS PubMed PubMed Central Google Scholar
Salmon, H., Remark, R., Gnjatic, S. & Merad, M. Host tissue determinants of tumour immunity. Nat. Rev. Cancer 19, 215–227 (2019).
CAS PubMed PubMed Central Google Scholar
Peiseler, M. et al. Kupffer cell-like syncytia replenish resident macrophage function in the fibrotic liver. Science 381, eabq5202 (2023).
Article CAS PubMed Google Scholar
Goto, N. et al. SOX17 enables immune evasion of early colorectal adenomas and cancers. Nature 627, 636–645 (2024).
Article CAS PubMed PubMed Central Google Scholar
Xiang, J. et al. Disruption of SIRT7 increases the efficacy of checkpoint inhibitor via MEF2D regulation of programmed cell death 1 ligand 1 in hepatocellular carcinoma cells. Gastroenterology 158, 664–678.e24 (2020).
Article CAS PubMed Google Scholar
Ma, L. et al. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2–M transition genes. Cancer Res. 74, 1452–1462 (2014).
Article CAS PubMed Google Scholar
Xiang, J. et al. A ubiquitin-dependent switch on MEF2D senses pro-metastatic niche signals to facilitate intrahepatic metastasis of liver cancer. Adv. Sci. (Weinh.) 10, e2305550 (2023).
Gao, T. & Qian, J. EnhancerAtlas 2.0: an updated resource with enhancer annotation in 586 tissue/cell types across nine species. Nucleic Acids Res. 48, D58–D64 (2020).
Bakiri, L. et al. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation. J. Exp. Med. 214, 1387–1409 (2017).
Article CAS PubMed PubMed Central Google Scholar
Filliol, A. et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610, 356–365 (2022).
Article CAS PubMed PubMed Central Google Scholar
Aran, D. et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat. Commun. 8, 1077 (2017).
Article PubMed PubMed Central Google Scholar
Nault, J. C. et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat. Commun. 4, 2218 (2013).
Berardi, D. E. et al. Lipid droplet turnover at the lysosome inhibits growth of hepatocellular carcinoma in a BNIP3-dependent manner. Sci. Adv. 8, eabo2510 (2022).
Article CAS PubMed PubMed Central Google Scholar
Piguet, A.-C. et al. Regular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis. J. Hepatol. 62, 1296–1303 (2015).
Article CAS PubMed Google Scholar
Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Invest. 113, 1774–1783 (2004).
Comments (0)